Inventor · disambiguated record
Srinath Kasturirangan
Also filed as: KASTURIRANGAN SRINATH
13 granted patents·7 pending applications·44 citations·filing 2010–2024
89Inventor score
Files withMEDIMMUNE LLC10SIERKS MICHAEL3ASTRAZENECA AB2BOEHRINGER INGELHEIM INT2ARIZONA BOARD OF REGENTS A BODY CORP OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF1
Top patents by PatentIndex Score
20 records- 0195US10442854B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Oct 15, 2019·13 cites·11 claims
- 0293US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0389USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 0489US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 0589US10882897B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Jan 5, 2021·3 cites·14 claims
- 0687US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0784US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0882US11926657B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2022·Granted Mar 12, 2024·0 cites·13 claims
- 0981US8617549B2Bispecific nanobodies as a therapeutic for alzheimer's diseaseSIERKS MICHAEL·Filed 2010·Granted Dec 31, 2013·7 cites·18 claims
- 1075US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 1172US9567393B2Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloidSIERKS MICHAEL·Filed 2011·Granted Feb 14, 2017·1 cites·8 claims
- 1272US9340606B2Immunization with amyloid-beta oligomersSIERKS MICHAEL·Filed 2011·Granted May 17, 2016·1 cites·12 claims
- 1372US2024360226A1Antibody molecules and conjugatesASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1471US12065496B2Antibody molecules and conjugatesASTRAZENECA AB·Filed 2022·Granted Aug 20, 2024·0 cites·27 claims
- 1571US11524993B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Dec 13, 2022·0 cites·14 claims
- 1669US2019185553A1Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloidARIZONA BOARD OF REGENTS OF BEHALF OF ARIZONA STATE UNIV·Filed 2019·Application pending·0 cites
- 1762US2017204170A1Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloidARIZONA BOARD OF REGENTS A BODY CORP OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF·Filed 2016·Application pending·0 cites
- 1861US2024052065A1Binding molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1957US12275798B2Tri-specific binding moleculesBOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 15, 2025·0 cites·17 claims
- 2054US2025121104A1Egfr-cmet-targeted compounds and uses thereofFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →